Long-Term Efficacy of Vedolizumab in Pediatric Inflammatory Bowel Disease

被引：0
|
作者：
Sarles, Harry E., Jr.
Whitney, Annette E.
Kuten, Samantha A.
Van Anglen, Lucinda J.
机构：
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000594116.32306.0b
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1147
引用
收藏
页码：S643 / S644
页数：2
相关论文
共 50 条
  • [41] Inflammatory bowel disease: long-term therapeutic challenges
    Ashton, James J.
    Green, Zachary
    Kolimarala, Vinod
    Beattie, R. Mark
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1049 - 1063
  • [42] LONG-TERM PROGNOSIS OF INFLAMMATORY BOWEL-DISEASE
    FARMER, RG
    POSTGRADUATE MEDICINE, 1981, 70 (04) : 124 - &
  • [43] Efficacy and Safety of Vedolizumab for Inflammatory Bowel Disease in Clinical Practice
    Chaudrey, Khadija
    Lightner, Amy
    Singh, Siddharth
    Faubion, William
    Tremaine, William
    Bruining, David
    Papadakis, Konstantinos
    Kisiel, John
    CoelhoPrabhu, Nayantara
    Raffals, Laura
    Kane, Sunanda
    Loftus, Edward, Jr.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S19 - S20
  • [44] Efficacy and Safety of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease
    Navaneethan, Udayakumar
    Kommaraju, Kiran Kumar
    Edminster, Timothy
    Zhu, Xiang
    Wilson, Kenneth
    Glover, Sarah C.
    GASTROENTEROLOGY, 2016, 150 (04) : S812 - S812
  • [45] Efficacy of Vedolizumab for Inflammatory Bowel Disease in the Setting of DiGeorge Syndrome
    Thau, Eve
    Moore, Hillary Aaron
    Stein, Philip
    Chen, Kathy
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2019, 68 (05): : E88 - E88
  • [46] Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels
    Huettemann, Eva
    Muzalyova, Anna
    Groehl, Katharina
    Nagl, Sandra
    Fleischmann, Carola
    Ebigbo, Alanna
    Classen, Johanna
    Wanzl, Julia
    Prinz, Friederike
    Mayr, Patrick
    Schnoy, Elisabeth
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [47] Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials
    Feagan, Brian G.
    Sandborn, William J.
    Colombel, Jean-Frederic
    O'Byrne, Sharon
    Khalid, Javaria M.
    Kempf, Christian
    Geransar, Parnia
    Bhayat, Fatima
    Rubin, David T.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (01): : 50 - 57
  • [48] Can induction and maintenance serum vedolizumab levels predict long-term clinical outcome in inflammatory bowel disease (IBD)?
    Miller, C.
    Morgan, H.
    Steel, A.
    Wahed, M.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S413 - S414
  • [49] Long-term effectiveness and safety of vedolizumab (VDZ) in inflammatory bowel disease (IBD): Results from the Spanish ENEIDA Registry
    Chaparro, M.
    Garre, A.
    Alfaro, I.
    Iborra, M.
    Mesonero, P.
    Vera Mendoza, I.
    Rodriguez, A.
    Miquel-Cusachs, J.
    Riestra, S.
    Navarro, P.
    De Castro Parga, L.
    Gonzalez-Munoza, C.
    Rivero Tirado, M.
    Manosa, M.
    Fernandez Salazar, L.
    Garcia-Sepulcre, M.
    Guardiola, J.
    Cabriada, J.
    Gutierrez Casbas, A.
    Sicilia, B.
    Perez Calle, J. L.
    Piqueras, M.
    Guerra, I.
    Roncero, O.
    Navarro-Llavat, M.
    Sainz, E.
    Barrio, J.
    Calvet, X.
    Garcia, A.
    Llorente Barrio, M.
    Lorente, R.
    Almela, P.
    Madrigal, R.
    Lucendo Villarin, A. J.
    Pajares, R.
    Van Domselaar, M.
    Legido Gil, J.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S447 - S448
  • [50] Long-term Health Outcomes in Pediatric Inflammatory Bowel Disease: A Population-based Study
    Turunen, Pieta
    Ashorn, Merja
    Auvinen, Anssi
    Iltanen, Sari
    Huhtala, Heini
    Kolho, Kaija-Leena
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (01) : 56 - 62
12345